Drug regimens affect cadaveric kidney graft survival.
Kauffman
H M
HM
United Network for Organ Sharing, Richmond, Virginia, USA.
Cherikh
W S
WS
Delmonico
F L
FL
D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D015999:Multivariate Analysis; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D016017:Odds Ratio; D016559:Tacrolimus / Q000627:therapeutic use
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine; D016559:Tacrolimus